Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors

Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors

US Patent 8431568 · Granted Apr 30, 2013

Estimated economic value: $255,737,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022
Salts of prodrugs of piperazine and substituted piperidine antiviral agents2022
Benzofuran derivatives for the treatment of hepatitis C2021
Square light2021
Taillight2021
Inhibitors of human immunodeficiency virus replication2021
Inhibitors of human immunodeficiency virus replication2021
Round light2021
Bracket light2020
Fog light2020
Headlight2020